Editing Template:PMIPartnerTableMarketingAndPR
Warning: You are not logged in. Your IP address will be publicly visible if you make any edits. If you log in or create an account, your edits will be attributed to your username, along with other benefits.
The edit can be undone.
Please check the comparison below to verify that this is what you want to do, and then save the changes below to finish undoing the edit.
Latest revision | Your text | ||
Line 329: | Line 329: | ||
List of Philip Morris International presentations: | List of Philip Morris International presentations: | ||
− | *Comprehensive Chemical Characterization of the Aerosol Generated by Heated Tobacco Product | + | *Comprehensive Chemical Characterization of the Aerosol Generated by Heated Tobacco Product |
− | *Toxicological Assessment of Flavored e-liquids in Sprague Dawley Rats in an OECD Subchronic Inhalation Study Complemented by Systems Toxicology Endpoints | + | Presented by Mark Bentley, Senior Scientist RRP System Innovation |
− | *Development of a 3D Intestinal Model for Assessing the Immunomodulatory Properties of Anti-inflammatory Compounds | + | *Toxicological Assessment of Flavored e-liquids in Sprague Dawley Rats in an OECD Subchronic Inhalation Study Complemented by Systems Toxicology Endpoints |
− | *Influence of the Introduction of Heated Tobacco Products on IHD and COPD Hospitalizations in Japan using Real-World Data | + | Presented by Jenny Ho, Scientist Study Management |
− | *Qualitative Health and Functioning Concept Elicitation Interviews in Japanese Users of Heated Tobacco Products | + | *Toxicological Assessment of Flavored e-liquids in Sprague Dawley Rats in an OECD Subchronic Inhalation Study Complemented by Systems Toxicology Endpoints |
− | *Scientific Substantiation of the Absence of Combustion in a Novel Heated Tobacco Product | + | Presented by Jenny Ho, Scientist Study Management |
− | *Assessing the Effects of Switching from Cigarettes to the Tobacco Heating System Relative to Smoking Cessation on Biomarkers of Potential Harm – Additional Evidence on the Potential to Reduce the Risk of Smoking-related Diseases | + | *Development of a 3D Intestinal Model for Assessing the Immunomodulatory Properties of Anti-inflammatory Compounds |
− | *IQOS Use Prevalence and History of Tobacco Product Use: Findings from Surveys in Japan, Italy, and Germany | + | Presented by Dr. Diego Marescotti, Manager High Content Screening |
+ | *Influence of the Introduction of Heated Tobacco Products on IHD and COPD Hospitalizations in Japan using Real-World Data | ||
+ | Presented by Dr. Angela van der Plas, Manager Real World Evidence | ||
+ | *Qualitative Health and Functioning Concept Elicitation Interviews in Japanese Users of Heated Tobacco Products | ||
+ | Presented by Dr. Esther Afolalu, Senior Behavioral Scientist | ||
+ | *Scientific Substantiation of the Absence of Combustion in a Novel Heated Tobacco Product | ||
+ | Presented by Dr. Giuseppe Plebani, Manager Scientific & Medical Affairs | ||
+ | *Assessing the Effects of Switching from Cigarettes to the Tobacco Heating System Relative to Smoking Cessation on Biomarkers of Potential Harm – Additional Evidence on the Potential to Reduce the Risk of Smoking-related Diseases | ||
+ | Presented by Dr. Christelle Haziza, Global Head Clinical Research & Execution | ||
+ | *IQOS Use Prevalence and History of Tobacco Product Use: Findings from Surveys in Japan, Italy, and Germany | ||
+ | Presented by Dr. Karina Fischer, Manager PBA/Post Launch Research | ||
<ref> PMI Science, [https://web.archive.org/save/https://www.pmiscience.com/whats-new/pmi-science-srnt-2021 PMI Science at SRNT 2021], 24 February 2021, Accessed 11 May 2021 </ref> | <ref> PMI Science, [https://web.archive.org/save/https://www.pmiscience.com/whats-new/pmi-science-srnt-2021 PMI Science at SRNT 2021], 24 February 2021, Accessed 11 May 2021 </ref> | ||
|2021 | |2021 |